Skip to content

A Randomized Controlled Trial on Twagadi Leha and Vyaghri Haritaki in Chronic Bronchitis

A Randomized Controlled Trial on Twagadi Leha with Vyaghri Haritaki in the Management of Kaphaja Kasa with special reference to Chronic Bronchitis. - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072384
Enrollment
132
Registered
2024-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J411- Mucopurulent chronic bronchitis

Interventions

None listed

Sponsors

Dr Mayuri Shingnapurkar
Lead Sponsor
Bhausaheb Mulak Ayurved Mahavidyalaya NAgpur
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex aged between 18 to 60 years. 2. Patients having any of following two or more signs and symptoms of Kaphaja Kasa described in the text – Kasa (cough), Anga Gaurava, Shirogaurava, Shirashoola (Headache), Kaphasampoorna ura, Nishtheevan (Sputum) & Aruchi (Anorexia). 3. Patient with history of uncomplicated Chronic Bronchitis. 4. Patients having PEFR = 50% of the predicted value. 5. Patients willing and able to participate in the study for 12 weeks.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from Acute Bronchitis. 2. Patients having PEFR 160/100mm of hg) 6. Patients on medication with corticosteroids, bronchodilators, mast cell stabilizers, antidepressants, anti-cholinergic, etc. or any other drugs that may have an influence on the outcome of the study in last 30 days. 7. Patients with viral Hepatitis. 6. Tobacco eaters and/or smokers. 9. Pregnant or lactating women 10. Patients who are not willing to give informed consent.

Design outcomes

Primary

MeasureTime frame
Evaluation of the effect of Twagadi Leha with the help of spirometry parameters.(Peak Expiratory Flow rate and Forced expiratory volume 1) 2. To find an alternative treatment medicine for Chronic Bronchitis.Timepoint: Day 0, end of 4 weeks, 8 weeks, 12 weeks.

Secondary

MeasureTime frame
Evaluation of the efficacy of Twagadi Leha in Chronic Bronchitis with respect to improvement in the quality of life with the help of questionnaire. Also subjective parameters will be assessed.Timepoint: Assessed on day 0, at the end 4 weeks, 8 weeks & 12 weeks. And at the 0 day, at the end of 8 weeks & 12 weeks respectively.

Countries

India

Contacts

Public ContactDr Mayuri Shingnapurkar

Government Ayurved Hospital Nagpur

jayant.gulhane.62.6@gmail.com9511828972

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026